These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33941092)

  • 1. Sampling strategies to evaluate the prognostic value of a new biomarker on a time-to-event end-point.
    Graziano F; Valsecchi MG; Rebora P
    BMC Med Res Methodol; 2021 Apr; 21(1):93. PubMed ID: 33941092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Clinical Cohort Data Using Nested Case-control and Case-cohort Sampling Designs. A Powerful and Economical Tool.
    Ohneberg K; Wolkewitz M; Beyersmann J; Palomar-Martinez M; Olaechea-Astigarraga P; Alvarez-Lerma F; Schumacher M
    Methods Inf Med; 2015; 54(6):505-14. PubMed ID: 26108707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Goodness-of-fit two-phase sampling designs for time-to-event outcomes: a simulation study based on New York University Women's Health Study for breast cancer.
    Lee M; Chen J; Zeleniuch-Jacquotte A; Liu M
    BMC Med Res Methodol; 2023 May; 23(1):119. PubMed ID: 37208600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which patients to sample in clinical cohort studies when the number of events is high and measurement of additional markers is constrained by limited resources.
    Edelmann D; Ohneberg K; Becker N; Benner A; Schumacher M
    Cancer Med; 2020 Oct; 9(20):7398-7406. PubMed ID: 32813923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new comparison of nested case-control and case-cohort designs and methods.
    Kim RS
    Eur J Epidemiol; 2015 Mar; 30(3):197-207. PubMed ID: 25446306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease.
    Ganna A; Reilly M; de Faire U; Pedersen N; Magnusson P; Ingelsson E
    Am J Epidemiol; 2012 Apr; 175(7):715-24. PubMed ID: 22396388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust risk prediction with biomarkers under two-phase stratified cohort design.
    Payne R; Yang M; Zheng Y; Jensen MK; Cai T
    Biometrics; 2016 Dec; 72(4):1037-1045. PubMed ID: 27037494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of incidence and prognosis from 'extreme' case-control designs.
    Salim A; Ma X; Fall K; Andrén O; Reilly M
    Stat Med; 2014 Dec; 33(30):5388-98. PubMed ID: 24980445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis and asymptotic theory for nested case-control designs under highly stratified proportional hazards models.
    Goldstein L; Langholz B
    Lifetime Data Anal; 2023 Apr; 29(2):342-371. PubMed ID: 36472759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-phase designs with current status data.
    Mao F; Cook RJ
    Stat Med; 2023 Apr; 42(8):1207-1232. PubMed ID: 36690474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crude incidence in two-phase designs in the presence of competing risks.
    Rebora P; Antolini L; Glidden DV; Valsecchi MG
    BMC Med Res Methodol; 2016 Jan; 16():5. PubMed ID: 26754746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating longitudinal markers under two-phase study designs.
    Maziarz M; Cai T; Qi L; Lok AS; Zheng Y
    Biostatistics; 2019 Jul; 20(3):485-498. PubMed ID: 29912281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating prognostic accuracy of biomarkers in nested case-control studies.
    Cai T; Zheng Y
    Biostatistics; 2012 Jan; 13(1):89-100. PubMed ID: 21856652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure stratified case-cohort designs.
    Borgan O; Langholz B; Samuelsen SO; Goldstein L; Pogoda J
    Lifetime Data Anal; 2000 Mar; 6(1):39-58. PubMed ID: 10763560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic inference in general nested case-control designs.
    Feifel J; Dobler D
    Biometrics; 2021 Mar; 77(1):175-185. PubMed ID: 32145031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of two-phase sampling data with semiparametric additive hazards models.
    Sun Y; Qian X; Shou Q; Gilbert PB
    Lifetime Data Anal; 2017 Jul; 23(3):377-399. PubMed ID: 26995733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint modeling of longitudinal and survival data with the Cox model and two-phase sampling.
    Fu R; Gilbert PB
    Lifetime Data Anal; 2017 Jan; 23(1):136-159. PubMed ID: 27007859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weighted analyses for cohort sampling designs.
    Gray RJ
    Lifetime Data Anal; 2009 Mar; 15(1):24-40. PubMed ID: 18712477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kernel machine testing for risk prediction with stratified case cohort studies.
    Payne R; Neykov M; Jensen MK; Cai T
    Biometrics; 2016 Jun; 72(2):372-81. PubMed ID: 26692376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cohort and nested case-control designs for estimating the effect of time-varying drug exposure on the risk of adverse event in the presence of ties.
    Manitchoko L; Abrahamowicz M; Tubert-Bitter P; Benichou J; Thiébaut ACM
    Biom J; 2023 Aug; 65(6):e2100384. PubMed ID: 36846937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.